PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
24-Nov-2020 Profacgen Provides Comprehensive Solutions for PEGylation Profacgen
24-Nov-2020 Oculis to Present Progress in its Portfolio of Novel Topical Treatments for Retinal and Front-of-the-Eye Diseases at Upcoming Investor Conferences Oculis S.A.
24-Nov-2020 Immunocore’s tebentafusp demonstrates superior overall survival compared to investigator’s choice in a Phase 3 clinical trial of patients with previously untreated metastatic uveal melanoma Immunocore
24-Nov-2020 Allero Therapeutics and Abbreos Join Forces to Clinically Develop COVID-19 Program Allero Therapeutics
24-Nov-2020 Targovax demonstrates encouraging survival data for ONCOS-102 in mesothelioma Targovax
24-Nov-2020 Alfa Chemistry Testing Lab: Pharmaceutical Impurity Testing Services to Assist Drug Development Alfa Chemistry Testing Lab
24-Nov-2020 FDA Approves First Drug to Treat Rare Metabolic Disorder U.S. Food and Drug Administration
23-Nov-2020 REGENXBIO to Present at Upcoming Investor Conferences REGENXBIO Inc.
23-Nov-2020 New Medical School Campus Slated for Temple, Texas Temple Economic Development Corporation; Temple Health & Bioscience District
23-Nov-2020 IPA Selects Polytope(TM) Formulations for Pre-Clinical Studies ImmunoPrecise Antibodies Ltd.
23-Nov-2020 BioLineRx Reports Third Quarter 2020 Financial Results and Provides Corporate Update BioLineRx Ltd.
23-Nov-2020 Leap Therapeutics to Participate at Piper Sandler 32nd Annual Virtual Healthcare Conference Leap Therapeutics, Inc.
23-Nov-2020 BrainStorm to present NurOwn® Phase 3 Clinical Trial Results at 31st International Symposium on ALS/MND BrainStorm Cell Therapeutics Inc.
23-Nov-2020 Milestone Pharmaceuticals to Present at Upcoming Investor Conferences Milestone Pharmaceuticals, Inc.
23-Nov-2020 CytoSorbents to Present at the Piper Sandler 32nd Annual Healthcare Conference CytoSorbents Corporation
23-Nov-2020 RESILIENCE Launches to Change the Future of Medicine through Manufacturing Innovation National Resilience, Inc.
23-Nov-2020 Medicen Paris Region and IBEC join forces to create the first Bioengineering and Medtech Against Cancer event on November 24 and 25, 2020 Andrew Lloyd Associates
23-Nov-2020 Juergen Ernst to retire from Pharming's Board of Supervisory Directors after more than 11 years of distinguished service Pharming Group N.V.
23-Nov-2020 Creation of a research partnership between Pierre Fabre and Y-Biologics for the development of new immunotherapies based on monoclonal antibodies Pierre Fabre and Y-Biologics
22-Nov-2020 Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19 U.S. Food and Drug Administration